Drug Discovery & Development |
Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health
COPD News Today Boehringer Ingelheim Pharmaceuticals and Propeller Health are partnering to use digital health tools and services to help patients with asthma and chronic obstructive pulmonary disease (COPD) to better cope with their condition. Under the terms of the … FDA Approves Supplemental New Drug Application (sNDA) for Boehringer Ingelheim's STIOLTO RESPIMAT for COPD … Boehringer Ingelheim Enters Commercial Partnership with Propeller Health |
View full post on asthma – Google News